missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Cell Lines and Blood Products
  4. Sera
  5. Serum Substitutes
  6. 17189951

STEMCELL Technologies BIT 9500 Serum Substitute

Serum substitute for culturing human and mouse hematopoietic cells

Brand:  STEMCELL Technologies 09500

Encompass

Product Code. 17189951

  • 750.00€ / 100mL
Estimated Shipment: 27-03-2025
to see stock.
Explore more special offers
Add to basket
This item is not returnable. View return policy

Description

Description

  • BIT 9500 Serum Substitute has been developed for use in applications where a serum-free culture medium of defined composition is required
  • This product contains bovine serum albumin (BSA), insulin, and transferrin (BIT) in Iscove's MDM
  • It contains pre-screened batches of BSA that have been selected to support the optimal growth of human hematopoietic progenitor cells in serum-free media formulations
  • It is also suitable for the culture of mouse hematopoietic progenitor cells in serum-free conditions
Specifications

Specifications

Hematopoietic Stem and Progenitor Cells; Hybridomas; Other; Pluripotent Stem Cells
100 mL
Cell Culture
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.